Peak bone mass acquisition during adolescence is an important determinant of adult bone health. Knowledge about the effects of different contraceptives on peak bone mass acquisition could influence choice of method recommended. This review summarizes normal bone acquisition during adolescence, discusses methods of assessing bone health in this age group, and reviews the effects of different contraceptive options on bone health, both in adults and in adolescents. Based on the evidence, long-acting reversible contraceptives do not appear to affect peak bone mass acquisition or future fracture risk and remain the first-line contraceptive choice for adolescents. Oral contraceptives with doses of ethinyl estradiol greater than 30 μg should be used in preference to lower-dose preparations, and the adverse effects of depo medroxyprogesterone acetate (DMPA) on bone health are reversible on discontinuation of the medication. Concerns about bone health should not prevent use of DMPA in an adolescent who prefers this method.

中文翻译：

---

青春期女孩的骨骼和节育。

青春期的峰值骨量获取是成人骨骼健康的重要决定因素。有关不同避孕药具对峰值骨量获取的影响的知识可能会影响推荐的方法的选择。这篇综述总结了青春期的正常骨骼获取情况，讨论了评估该年龄组骨骼健康的方法，并回顾了不同避孕方法对成年人和青少年骨骼健康的影响。根据证据，长效可逆避孕药似乎不影响峰值骨量获取或未来骨折的风险，并且仍然是青少年的首选避孕药。乙炔雌二醇大于30μg的口服避孕药应优先于小剂量制剂使用，停用醋酸甲羟孕酮（DMPA）对骨骼健康的不良影响在药物停用后是可逆的。对骨骼健康的担忧不应阻止喜欢这种方法的青少年使用DMPA。